Newswise — New York, NY – March 31, 2016 – The Cardiovascular Research Foundation (CRF) announced today that Daniel Burkhoff, MD, PhD, has returned to the organization as Director of Heart Failure, Hemodynamics and Circulatory Support in the CRF Clinical Trials Center (CTC).
A world-renowned expert in heart failure and hemodynamics, Dr. Burkhoff will focus his efforts on advancing hemodynamic education, and will collaborate on heart failure research initiatives across all divisions of CRF. Dr. Burkhoff is the creator of the Harvi simulator, an interactive application that gives healthcare providers a better understanding of the fundamentals of hemodynamics. It was designed to help educate physicians at all levels of training on hemodynamics and to assist them in predicting the effects of different therapies, as well as aid in patient selection for new device therapies. Dr. Burkhoff will work with the CRF Center for Education (CED) to develop novel curricula using Harvi in educational programs for practicing physicians, fellows, and medical students around the world.
“We are very excited to welcome Dan back to CRF,” said Martin B. Leon, MD, Founder and Chairman Emeritus of CRF and Co-Director of Medical Research and Education. “He is a widely respected researcher and innovator whose expertise will enhance our efforts to advance the field and develop new educational programs and teaching tools for the next generation of physicians and investigators. His work underscores the value of understanding the role of circulatory support and unloading the LV in relation to myocardial recovery and high risk PCI procedures. Dan’s efforts will undoubtedly change the way cardiovascular physiology is taught and applied to the everyday treatment of patients suffering from heart disease.”
“Dr. Burkhoff’s unique background and experience will boost the capabilities of the CRF Clinical Trials Center in heart failure and hemodynamics research, as well as help bring innovative new technologies, therapies, and treatments to patients with cardiovascular disease,” said Ori Ben-Yehuda, MD, Executive Director of the CTC.
“I am thrilled to return to CRF, an organization with a distinguished reputation for innovation and countless contributions to cardiology and patient care,” said Dr. Burkhoff. “Working with CRF’s exceptional physician leaders, as well as CRF’s vast network of physician colleagues, I am excited by the opportunity to expand the scientific and medical community’s understanding of heart function and hemodynamics.”
Dr. Burkhoff was instrumental in the creation of the CRF Skirball Center for Innovation, and served as Director when it opened in 2005. He is an Adjunct Associate Professor at Columbia University. Before returning to CRF, he was Vice President of Medical Science for HeartWare International. Previously, he has served as Medical Director of CircuLite and Cheetah Medical. He received his medical and doctor of philosophy degrees from The Johns Hopkins School of Medicine and completed his cardiology fellowship at The Johns Hopkins Hospital.
About CRFThe Cardiovascular Research Foundation (CRF) is a nonprofit research and educational organization dedicated to helping doctors improve survival and quality of life for people suffering from heart and vascular disease. For over 25 years, CRF has helped pioneer innovations in interventional cardiology and has educated doctors on the latest treatments for heart disease.
The CRF Clinical Trials Center (CTC) is a distinguished academic research organization which has contributed to key advances in the treatment of cardiovascular disease and played an essential role in bringing new devices and therapies to patients. The CTC specializes in trial design, imaging core labs, event adjudication, data and safety monitoring boards, and biostatistical services.
The CRF Center for Education trains interventional cardiologists and other healthcare professionals in advanced techniques and innovations at more than 50 educational meetings and conferences each year, including the Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.
The CRF Skirball Center for Innovation (SCI) guides early ideas and innovations through comprehensive preclinical research programs to introduce practical clinical therapies to patients. SCI is the premier destination for those seeking to develop and validate new cardiovascular technologies, as well as hands-on training for novel devices.
For more information, visit www.crf.org.